nasdaq:vtrs
|
https://www.indeed.com/cmp/mylan
|
Aug 29th, 2022 12:00AM
|
Open
|
Mylan
|
|
Pharmaceutical & Biotechnology
|
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which approximately 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com/careers.
|
RRv1_OVER_10B
|
Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317
|
Heather Bresch
|
|
|
3.70
|
72.0
|
63.0
|
64.0
|
63.0
|
59.0
|
59.0
|
53.0
|
65.0
|
55.0
|
57.0
|
59.0
|
65.0
|
69.0
|
168.0
|
995.00
|
995.00
|
3.30
|
4.00
|
3.20
|
3.30
|
3.50
|
121.00
|
More than one month
|
129.00
|
MEDIUM
|
133.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:47PM
|
Aug 29th, 2022 12:47PM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/viatris
|
Aug 29th, 2022 12:00AM
|
Open
|
Viatris
|
|
Pharmaceutical & Biotechnology
|
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
|
|
We have employees worldwide and operate three global centers based in Pittsburgh, Pennsylvania, United States; Shanghai, China; and Hyderabad, India.
|
Michael Goettler
|
|
|
3.70
|
64.0
|
67.0
|
62.0
|
59.0
|
51.0
|
50.0
|
52.0
|
53.0
|
48.0
|
55.0
|
50.0
|
62.0
|
63.0
|
37.0
|
21.00
|
21.00
|
3.30
|
3.70
|
2.70
|
2.80
|
3.60
|
|
|
6.00
|
MEDIUM
|
6.00
|
AVERAGE
|
|
|
|
Aug 29th, 2022 12:47PM
|
Aug 29th, 2022 12:47PM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/viatris
|
Aug 28th, 2022 12:00AM
|
Open
|
Viatris
|
|
Pharmaceutical & Biotechnology
|
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
|
|
We have employees worldwide and operate three global centers based in Pittsburgh, Pennsylvania, United States; Shanghai, China; and Hyderabad, India.
|
Michael Goettler
|
|
|
3.70
|
64.0
|
67.0
|
62.0
|
59.0
|
51.0
|
50.0
|
52.0
|
53.0
|
48.0
|
55.0
|
50.0
|
62.0
|
63.0
|
37.0
|
21.00
|
21.00
|
3.30
|
3.70
|
2.70
|
2.80
|
3.60
|
|
|
6.00
|
MEDIUM
|
6.00
|
AVERAGE
|
|
|
|
Aug 28th, 2022 05:47AM
|
Aug 28th, 2022 05:47AM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/mylan
|
Aug 28th, 2022 12:00AM
|
Open
|
Mylan
|
|
Pharmaceutical & Biotechnology
|
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which approximately 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com/careers.
|
RRv1_OVER_10B
|
Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317
|
Heather Bresch
|
|
|
3.70
|
72.0
|
63.0
|
64.0
|
63.0
|
59.0
|
59.0
|
53.0
|
65.0
|
55.0
|
57.0
|
59.0
|
65.0
|
69.0
|
168.0
|
995.00
|
995.00
|
3.30
|
4.00
|
3.20
|
3.30
|
3.50
|
121.00
|
More than one month
|
129.00
|
MEDIUM
|
133.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:47AM
|
Aug 28th, 2022 05:47AM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/viatris
|
Aug 27th, 2022 12:00AM
|
Open
|
Viatris
|
|
Pharmaceutical & Biotechnology
|
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
|
|
We have employees worldwide and operate three global centers based in Pittsburgh, Pennsylvania, United States; Shanghai, China; and Hyderabad, India.
|
Michael Goettler
|
|
|
3.70
|
64.0
|
67.0
|
62.0
|
59.0
|
51.0
|
50.0
|
52.0
|
53.0
|
48.0
|
55.0
|
50.0
|
62.0
|
63.0
|
37.0
|
21.00
|
21.00
|
3.30
|
3.70
|
2.70
|
2.80
|
3.60
|
|
|
6.00
|
MEDIUM
|
6.00
|
AVERAGE
|
|
|
|
Aug 27th, 2022 05:05AM
|
Aug 27th, 2022 05:05AM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/mylan
|
Aug 27th, 2022 12:00AM
|
Open
|
Mylan
|
|
Pharmaceutical & Biotechnology
|
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which approximately 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com/careers.
|
RRv1_OVER_10B
|
Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317
|
Heather Bresch
|
|
|
3.70
|
72.0
|
63.0
|
64.0
|
63.0
|
59.0
|
59.0
|
53.0
|
65.0
|
55.0
|
57.0
|
59.0
|
65.0
|
69.0
|
168.0
|
995.00
|
995.00
|
3.30
|
4.00
|
3.20
|
3.30
|
3.50
|
121.00
|
More than one month
|
129.00
|
MEDIUM
|
133.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 05:05AM
|
Aug 27th, 2022 05:05AM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/mylan
|
Aug 25th, 2022 12:00AM
|
Open
|
Mylan
|
|
Pharmaceutical & Biotechnology
|
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which approximately 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com/careers.
|
RRv1_OVER_10B
|
Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317
|
Heather Bresch
|
|
|
3.70
|
72.0
|
63.0
|
64.0
|
63.0
|
59.0
|
59.0
|
53.0
|
65.0
|
55.0
|
57.0
|
59.0
|
65.0
|
69.0
|
168.0
|
994.00
|
994.00
|
3.30
|
4.00
|
3.20
|
3.30
|
3.50
|
121.00
|
More than one month
|
129.00
|
MEDIUM
|
133.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 09:45AM
|
Aug 25th, 2022 09:45AM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/viatris
|
Aug 25th, 2022 12:00AM
|
Open
|
Viatris
|
|
Pharmaceutical & Biotechnology
|
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
|
|
We have employees worldwide and operate three global centers based in Pittsburgh, Pennsylvania, United States; Shanghai, China; and Hyderabad, India.
|
Michael Goettler
|
|
|
3.70
|
64.0
|
67.0
|
62.0
|
59.0
|
51.0
|
50.0
|
52.0
|
53.0
|
48.0
|
55.0
|
50.0
|
62.0
|
63.0
|
37.0
|
20.00
|
20.00
|
3.30
|
3.70
|
2.70
|
2.80
|
3.60
|
|
|
6.00
|
MEDIUM
|
6.00
|
AVERAGE
|
|
|
|
Aug 25th, 2022 09:45AM
|
Aug 25th, 2022 09:45AM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/mylan
|
Aug 23rd, 2022 12:00AM
|
Open
|
Mylan
|
|
Pharmaceutical & Biotechnology
|
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which approximately 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com/careers.
|
RRv1_OVER_10B
|
Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317
|
Heather Bresch
|
|
|
3.70
|
72.0
|
63.0
|
64.0
|
63.0
|
59.0
|
59.0
|
53.0
|
65.0
|
55.0
|
57.0
|
59.0
|
65.0
|
69.0
|
168.0
|
994.00
|
994.00
|
3.30
|
4.00
|
3.20
|
3.30
|
3.50
|
121.00
|
More than one month
|
129.00
|
MEDIUM
|
133.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 11:38AM
|
Aug 23rd, 2022 11:38AM
|
Viatris
|
|
|
nasdaq:vtrs
|
https://www.indeed.com/cmp/viatris
|
Aug 23rd, 2022 12:00AM
|
Open
|
Viatris
|
|
Pharmaceutical & Biotechnology
|
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
|
|
We have employees worldwide and operate three global centers based in Pittsburgh, Pennsylvania, United States; Shanghai, China; and Hyderabad, India.
|
Michael Goettler
|
|
|
3.70
|
64.0
|
67.0
|
62.0
|
59.0
|
51.0
|
50.0
|
52.0
|
53.0
|
48.0
|
55.0
|
50.0
|
62.0
|
63.0
|
37.0
|
20.00
|
20.00
|
3.30
|
3.70
|
2.70
|
2.80
|
3.60
|
|
|
6.00
|
MEDIUM
|
6.00
|
AVERAGE
|
|
|
|
Aug 23rd, 2022 11:38AM
|
Aug 23rd, 2022 11:38AM
|
Viatris
|
|
|